ApoE4 appears to have a less effective anti-inflammatory function, even being a pro-inflammatory factor, when compared to other apoE isoforms (2), aggravating the neurological damage and clinical outcomes in various conditions, such as Alzheimer's disease and stroke. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.